BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17920819)

  • 21. 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
    Roig J; Casal J; Gispert P; Gea E
    Med Mal Infect; 2006; 36(11-12):680-9. PubMed ID: 17095177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multiplex PCR-based reverse line blot hybridization (mPCR/RLB) assay for detection of bacterial respiratory pathogens in children with pneumonia.
    Wang Y; Kong F; Yang Y; Gilbert GL
    Pediatr Pulmonol; 2008 Feb; 43(2):150-9. PubMed ID: 18085683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-acquired pneumonia in children in Lambarene, Gabon.
    Lassmann B; Poetschke M; Ninteretse B; Issifou S; Winkler S; Kremsner PG; Graninger W; Apfalter P
    Am J Trop Med Hyg; 2008 Jul; 79(1):109-14. PubMed ID: 18606773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usefulness of sputum gram stain and culture.
    Musher DM
    Arch Intern Med; 2005 Feb; 165(4):470-1. PubMed ID: 15738381
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe community-acquired pneumonia (CAP) treated at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W; Pisprasert V
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):430-3. PubMed ID: 15691151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community acquired bacterial pneumonia: aetiology, laboratory detection and antibiotic susceptibility pattern.
    Akter S; Shamsuzzaman SM; Jahan F
    Malays J Pathol; 2014 Aug; 36(2):97-103. PubMed ID: 25194532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)].
    Bantar C; Curcio D; Jasovich A; Bagnulo H; Arango A; Bavestrello L; Famiglietti A; García P; Lopardo G; Losanovscky M; Martínez E; Pedreira W; Piñeyro L; Remolif C; Rossi F; Varón F
    Rev Chilena Infectol; 2010 Jun; 27 Suppl 1():S9-S38. PubMed ID: 20737129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited usefulness of initial blood cultures in community acquired pneumonia.
    Corbo J; Friedman B; Bijur P; Gallagher EJ
    Emerg Med J; 2004 Jul; 21(4):446-8. PubMed ID: 15208227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Community-acquired pneumonia--current status of pathogen diagnosis].
    Mittermayer H
    Acta Med Austriaca; 1997; 24(1):8-9. PubMed ID: 9206930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal community-acquired pneumonia: pathogens and treatment.
    Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D
    J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia.
    Endeman H; Schelfhout V; Voorn GP; van Velzen-Blad H; Grutters JC; Biesma DH
    Scand J Infect Dis; 2008; 40(9):715-20. PubMed ID: 19086245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotics in childhood pneumonia.
    Hale KA; Isaacs D
    Paediatr Respir Rev; 2006 Jun; 7(2):145-51. PubMed ID: 16765302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of pre-hospital antibiotic use on community-acquired pneumonia.
    Simonetti AF; Viasus D; Garcia-Vidal C; Grillo S; Molero L; Dorca J; Carratalà J
    Clin Microbiol Infect; 2014 Sep; 20(9):O531-7. PubMed ID: 24707906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial etiologies in community acquired pneumonia (CAP).
    Szmygin-Milanowska K; Kieszko R; Chudnicka A; Milanowski J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):466-74. PubMed ID: 15315033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia.
    Afzal Z; Minard CG; Stager CE; Yu VL; Musher DM
    Am J Ther; 2016; 23(3):e766-72. PubMed ID: 24351801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.